期刊文献+

结直肠癌组织中ABCG2蛋白的表达及其与CPT-11化疗方案疗效的相关性

Expression of ABCG2 in colorectal cancer tissues and its correlation with efficacy of CPT-11 chemotherapy
下载PDF
导出
摘要 目的探讨结直肠癌组织中ABCG2蛋白的表达情况及其与CPT-11化疗方案疗效的相关性。方法选取结直肠癌住院患者89例。采用链霉菌抗生物素蛋白-过氧化物酶连结法检测ABCG2表达情况,分析结直肠癌组织中ABCG2蛋白的表达情况与CPT-11化疗方案疗效的相关性,并分析ABCG2蛋白的表达情况与患者年龄、性别等临床资料的相关性。结果89例直肠癌住院患者组织标本中,阳性率达89.89%。52例临近正常肠黏膜组织标本中,阳性率为48.08%,表明结直肠癌组织中ABCG2表达较正常肠黏膜组织显著升高(P<0.05)。结直肠癌组织标本ABCG2表达情况与患者年龄、性别、分化程度、病变部位、肝转移无相关性(P>0.05)。结直肠癌组织标本ABCG2表达情况与CPT-11化疗疗效无相关性(P>0.05)。结论结直肠癌组织中ABCG2蛋白的表达情况与CPT-11化疗方案疗效无相关性。 Objective To explore the expression of ABCG2 in colorectal cancer tissues and its correlation with efficacy of CPT-11 chemotherapy. Methods A total of 89 patients with colorectal cancer were selected. The SP method was used to detect ABCG2 expression level. The correlation between the expression of ABCG2 and the efficacy of CPT-11 chemotherapy was analyzed,and correlations between the expression of ABCG2 and the patient's age,sex were analyzed as well. Results The positive rate was 89. 89% in 89 cases of rectal cancer. Positive rate was 48. 08% in 52 cases of normal intestinal mucosa,which showed that the expression of ABCG2 in colorectal carcinoma was significantly higher than that in normal intestinal mucosa( P〈0. 05). The expression of ABCG2 in colorectal cancer tissue showed no correlation with the age,sex,degree of differentiation,location of lesion and liver metastasis( P〉0. 05). Expression of ABCG2 in colorectal cancer tissue had no correlation with efficacy of CPT-11 chemotherapy efficacy( P〉0. 05). Conclusion There is no correlation between ABCG2 expression in colorectal cancer tissues and the efficacy of CPT-11 chemotherapy.
作者 朱礼
出处 《实用临床医药杂志》 CAS 2016年第19期40-43,共4页 Journal of Clinical Medicine in Practice
关键词 ABCG2 CPT-11 结直肠癌 ABCG2 CPT-11 colorectal cancer
  • 相关文献

参考文献5

二级参考文献69

  • 1赵亚超,张志培,韩勇,朱长亮,朱以芳,钟代星,程庆书.非小细胞肺癌组织BCRP和GST-π表达及其与化疗敏感性关系的研究[J].中华肿瘤防治杂志,2008,15(12):897-900. 被引量:4
  • 2胡潇红,沙卫红,林锋,岑荣英,王启仪,廖山婴.大肠癌组织中ABCG2的表达及临床病理意义[J].中华临床医师杂志(电子版),2011,5(12):3436-3440. 被引量:1
  • 3Qiang Zhang,Kun Li,Jian-Hua Xu,Cheng-Gen Zhao,Qi Gao,Bin Wu,Xiao-Yan Liu.Role of ABCG2 expression driven by cisplatin in platinumcontaining chemotherapy for gastric cancer[J].World Journal of Gastroenterology,2013,19(39):6630-6636. 被引量:2
  • 4JEMAL A,SIEGEL R,WARD E,et al.Cancer statistics[J].CA Cancer J Clin,2008,58(2):71-96.
  • 5INNOCENTI F,KROETZ D L,SCHUETZ E,et al.Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics[J].J Clin Oncol,2009,27(16):2604-2614.
  • 6ROUGIER P,MITRY E.Colorectal cancer chemotherapy:irinotecan[J].Semin Oncol,2000,27:138-143.
  • 7GILLET J P,EFFERTH T,REMACLE J.Chemotherapy-induced resistance by ATP-binding cassette transporter genes[J].Biochim Biophys Acta,2007,1775(2):237-262.
  • 8ECKFORD P D W,SHAROM F J.ABC efflux pump based resistance to chemotherapy drugs[J].Chem Rev,2009,109:2989-3011.
  • 9LO H W,ALI-OSMAN F.Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance[J].Curr Opin Pharmacol,2007,7(4):367-374.
  • 10FERGUSON D O,ALT F W.DNA double strand break repair and chromosomal translocation:lessons from animal models[J].Oncogene,2001,20(40):5572-5579.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部